Fig. 7From: Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient micePhosphor-ERK levels in the hearts of the three groups after 8 weeks with different treatments. a Immunoblotting for phosphor-ERK levels in heart tissues. b The bar graph shows the quantification of phosphor-ERK levels. Data are given as the means±SEM; n = 3 in each group. *P < 0.05 vs ApoE−/−HDBack to article page